UMIN ID: UMIN000016071
Registered date:28/12/2014
Phase II Study of Carboplatin+nab-Paclitaxel for Non-small Cell Lung Cancer with Interstitial Pneumonitis Study of evaluating SPARC expression
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Advanced non-small cell carcinoma with interstitial pneumoniae |
| Date of first enrollment | 2014/12/28 |
| Target sample size | 30 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | To evaluate the SPARC expression level of the tumor cells and interstitial cells utlizing the pathological specimens obtained from patients enrolled to the YLOG0114 study. |
|---|---|
| Secondary Outcome | To evaluate the relationship between SPARC expression leve, other factores and treatment effectiveness. |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 80years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | The cases excepting the above. |
Related Information
| Primary Sponsor | Yushima Lung Cancer Oncology Group (YLOG) |
|---|---|
| Secondary Sponsor | Institutes of Yushima Lung Oncology Group |
| Source(s) of Monetary Support | none,none |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Hiroyuki Sakashita |
| Address | 1-5-45 Yushima Bunkyoku, Tokyo Japan 113-8510 |
| Telephone | 03-5803-5954 |
| hsakpulm@tmd.ac.jp | |
| Affiliation | Postgraduate School of Tokyo Medical and Dental University Division of Clinical Oncology |
| scientific contact | |
| Name | Yasunari Miyazaki |
| Address | 1-5-45 Yushima Bunkyoku, Tokyo Japan |
| Telephone | 03-5803-5954 |
| ninase.pulm@tmd.ac.jp | |
| Affiliation | Tokyo Medical and Dental University Department of Respiratory Medicine |